Analysis of beta3 adrenergic receptor gene polymorphism using noninvasive samples obtained at scheduled infant health

M Tadokoro1, C Sato, N Takeda

  • 1Department of Hygiene and Public Health, School of Medicine, Kagawa Medical University, 761-0793, Miki-cho, Kagawa.

Insights

Infant obesity prevention is crucial. Genetic analysis using non-invasive samples like buccal mucosa and hair at health checkups is effective for identifying obesity risk factors in children.

Area of Science:

  • Pediatrics
  • Genetics
  • Public Health

Background:

  • Obesity is a significant risk factor for lifestyle-related diseases.
  • Intervention during infancy is more effective for weight control than in adulthood.
  • Infant health checkups are key opportunities for obesity prevention, but genetic analysis is challenging without blood samples.

Purpose of the Study:

  • To investigate the feasibility of genetic analysis for obesity prevention in infants using non-invasive samples.
  • To determine the effectiveness of typing beta3 adrenergic receptor gene polymorphism from buccal mucosa, hair, and cerumen.

Main Methods:

  • Collected buccal mucosa, hair, and cerumen samples from 96 infants at 18- and 36-month checkups.
  • Assessed the success rate of polymorphism typing from each non-invasive sample type.
  • Achieved high cooperation rates (94.1%) due to the non-invasive nature of sampling.

Main Results:

  • Buccal mucosa (approx. 76%) and hair (approx. 44%) samples yielded successful polymorphism typing.
  • Combined results from buccal mucosa and hair allowed typing for approximately 90% of infants.
  • Cerumen samples were largely unsuitable for genetic analysis (approx. 4%).

Conclusions:

  • Non-invasive genetic analysis from buccal mucosa and hair is practical for infant obesity prevention during routine health checkups.
  • This method shows potential for widespread application in mass screenings for genetic factors of various diseases.
  • Early genetic risk assessment in infants can facilitate timely obesity interventions.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...